Wearable Drug Delivery

Technology advances in insulin pumps, transdermal patches, micro needle patches and patch pumps

2-3 Oct 2018

GBP 1,499
EUR 2,099
USD 2,338

Book now

Conference Overview

The first “wearable” drug delivery device was developed in the early 1960s, a backpack which delivered insulin to the wearer. Smaller, more conveniently wearable, syringe-drivers were developed over the following decades for delivery of insulin. These type of devices are now universally known as insulin pumps and the latest versions are stuck directly onto the skin and controlled wirelessly. Ambulatory syringe drivers and bladder pumps are also used for chemotherapy and analgesia. From the 1980s onwards, wearable passive transdermal patches were developed for dosing a range of drugs such as hormones, analgesics, anti-hypertensives and nicotine to aid smoking cessation. Recently there has been emphasis on development of wearable pumps to deliver larger volumes of biologic drugs, which would be inconvenient to deliver by self-injection. This conference will review the current trends in the market and highlight the latest technology in this fast growing area.

Please note that this programme relates to the 2017 event. The new programme and brochure will be available shortly.

Please revisit this page in a few weeks time to see the programme for 2018.


Who Should Attend

This inaugural conference will be beneficial to all those who are interested in learning about, developing or sourcing wearable drug delivery devices. This includes pharmaceutical, medical device and drug delivery companies both large and small. The conference will be of particular interest to R&D, technical, medical, clinical, operating and marketing functions at all levels of management within these organisations.

Programme Day One

Chairmen’s welcome
Dr Gregory Berman

An overview of regulations, technology and advances

  • Introduction to some of the different ‘wearable’ technology types in drug delivery
  • Some considerations for ‘wearables’ opportunities
  • Highlights from the landscape of relevant regulations, standards and guidance
    Mark Chipperfield

Enterprise connected health and wearable drug delivery

  • Clinical drivers
  • Commercial drivers for connectivity
  • Regulatory considerations for connected devices
  • Stakeholder focused solution design and delivery
    Neil Williams

The regulatory framework for pumps and delivery systems

  • Classification – getting it right from the start
  • Implications of the new EU Medical Device Regulations for drug delivery systems
  • Developing a global device regulatory dossier for supporting drug
    Stephen M Dew

Omnipod Delivery System

  • The POD (Personal Diabetes Manager) communicate wirelessly to deliver continuous insulin based on patients’ personal settings
    Dave Nazzaro

Accu Chek Technology

  • Accu Chek insulin pump systems portfolio
  • Clinically proven bolus advisor
    Nicola Birtwistle

3d Lithographic printing of microneedles onto flexible substrate

  • Exploring multiple-layered, geometrically optimised structures printed onto different materials that conform to the surface of the body
  • Using pre-existing materials already used in medical applications for a less complex route to market
  • Permeation analysis and additional techniques show the effectiveness of the technology
    Ken Jones and Ryan Barnsey

Low power wireless solutions for wearable drug delivery systems

  • Bluetooth low energy is changing healthcare
  • Addressing market requirements on power, cost and size
  • Proof-of-concept for a highly integrated low power and low cost solution • Low power cellular, the next evolution for wearable drug delivery systems
    Thomas Soderholm

Success factors for commercializing connected wearable drug delivery devices

  • Focus: Patient engagement vs. Professional sales?
  • Data: What is required for successful reimbursement as well as future
    next gen digitally integrated product/ service development?
  • Internet of Things/data driven future roadmaps: Medical grade end to
    end data sharing and integration
    Thomas Olesen

Programme Day Two

Review of day one
Dr Gregory Berman

Wearable devices for clinical trials

  • Is there an emerging need for wearable devices in the clinical research arena?
  • Wearable medical devices, mobile medical applications or Apps?
  • What are the benefits and disadvantages of such systems in clinical
    Tony Bedford

Considerations for the use of wearables in clinical trial

  • Clinical requirements • Patient impact
  • Device and vendor
  • Data transfer
  • Data management
  • Regulatory guidance
    Marie McCarthy

Demand for large volume Injectors – An introduction to YpsoDose for 2-10ml injection volumes

  • Current trends for large volume injectors above 1ml • Introduction to YpsoDose wearable injector
  • YpsoDose: Usability and technical aspects
    Ian Thompson

Wearable Large Volume Injectors: One device – Multiple solutions

  • Viscosity and volume challenges with biologics – Increase in promising new biologics and biosimilars to treat multiple disease states
  • Subcutaneous injection of biologics: Overcoming the volume challenge
  • Wearable Large Volume Injectors (LVIs): An Elegant solution
  • Wider implications of wearable LVIs: A hand-in-glove fit with the new
    healthcare paradigm
  • Considerations in choosing a wearable high volume subcutaneous
    delivery device
  • Pharma-device partnerships: Early clinical collaboration
    Mike Hooven

West’s SmartDose Platform: a Wearable engineered with both patient and pharma partner in mind

  • Trends in today’s drug delivery for biologics
  • SmartDose® technology platform
  • Improving the patient experience through integrated approach
    Robbie Mulligan

Patch Pump ‘small and large volume’

  • Pump and dose technology • Sensile medical devices
  • Typical applications
    Dr Paul Senn

SteadyMed Patch Pump technology

  • PatchPump technology overview
  • TrevyentTM (treprostinil PatchPump) – single-use drug-device
    combination product for the treatment of Pulmonary Arterial
  • Next Generation infusion system – rapid subcutaneous delivery of
    large volume / high viscous drugs
    Assaf Shaked

Continuing professional development

This course qualifies for the following CPD programmes:

  • Certificate

Book now

2-3 Oct 2018
2-3 Oct 2018 Rembrandt Hotel, London GBP 1,499.00
EUR 2,099.00
USD 2,338.00
+ VAT @ 20.00%
Enrol now

You may also be interested in

Previous customers include...

  • 3P Innovation Ltd
  • Aptar France SAS
  • Ares Trading SA
  • Celanese
  • DCA Design International
  • LEO Pharma
  • MSD Animal Health
  • Nemera
  • Nemera La Verpilliere
  • Nordic Semiconductor
  • OnDrugDelivery Ltd
  • Owen Mumford Ltd
  • Pfizer Limited
  • Raumedic AG
  • SHL Group
  • Sonceboz SA
  • West Pharmaceutical Services

Diverse - good, well balanced in content and length

DanielAbrahamsson, Senior Device Engineer, LEO Pharma

Too commercial. Too wide and diverse in subject matters

MichaelMcGowan, Market Intelligence Director, SHL Group

Overall excellent, friendly and lively format and experience

PierreCarlotti, VP Strategic Marketing, Aptar France SAS